World Orphan Drug Congress Europe 2026

The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases.

From cell and gene therapy, genetic testing, and market access, to real world evidence, this one meeting covers the whole orphan drugs value chain where science, government and manufacturers all come together to create groundbreaking progress.

Join over 1,800 senior industry leaders, gain insights from 250+ expert speakers, and connect with over 100 exhibitors driving progress across the entire orphan drug lifecycle. From regulatory strategy and market access to patient engagement and the latest breakthroughs in gene and cell therapies, the congress delivers practical insights you can apply immediately.

Network with the most senior individuals across the industry, including leaders in R&D, gene therapy, rare diseases, precision/personalised medicine, genetic disorders, patient advocacy and engagement, associations in ATMPs, investors, regulatory affairs professions, governmental bodies, and more...

More information, here.